REFERENCES
- Chamberlain RE. Chemotherapeutic properties of prominent nitrofurans. J Antimicrob Chemother 1976; 2: 325–336
- McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994; 33: 23–30.
- McOsker CC, Pollack JR, Anderson JA. Inhibition of bacterial protein synthesis by nitrofurantoin macrocrystals: an explanation for the continued efficacy of nitrofurantoin. R Soc Med Int Congr Symp Ser 1989; 154: 33–44.
- Bryant C, DeLuca M. Purification and characterization of an oxygen-insensitive NAD(P)H nitroreductase from Enterobacter cloacae. J Biol Chem 1991; 266: 4119–4125.
- Heflich RH, Howard PC, Beland FA. 1-nitrosopyrene: an intermediate in the metabolic activation of 1-nitropyrene to a mutagen in Salmonella typhimurium. Mutat Res 1985; 149: 25–32.
- Tatsumi K, Kitamura S, Narai N. Reductive metabolism of aromatic nitrocompounds including carcinogens by rabbit liver preparations. Cancer Res 1986; 46: 1089–1093.
- Whiteway J, Koziarz P, Veall J, et al. Oxygen-insensi-tive nitroreductases: analysis of the roles of nsfA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli. J Bacteriol 1998; 180: 5529–5539.
- Gillette JR, Kamm JJ, Sasame HA. Mechanism of P-nitrobenzoate reduction in liver: the possible role of cytochrome P-450 in liver microsomes. Mol Pharmacol 1968; 4: 541–548.
- Kutcher WW, McCalla DR. Aerobic reduction of 5-nitro-furaldehyde semicarbazone by rat liver xanthine dehydroge-nase. Biochem Pharmacol 1984; 33: 799–805.
- Kato R, Takahashi A, Oshima T. Characteristics of nitro reduction of the carcinogenic agent, 4-nitroquinolone N-oxide. Biochem Pharmacol 1970: 19: 45–55.
- Rafii F, Hansen EB. Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract. Antimicrob Agents Chemother 1998; 42: 1121–1126.
- Shahverdi AR, Tavassoli F. First description on the nitrofurantoin potentiation activity. Dam, 2002; 10 (2): 90.
- Shahverdi A R Bagheri M, Tavassoli, F. A novel In vitro nitrofurantoin resistance breaker activity of Men tha longifolia L. essential oil. J Med Plants 2002; 1 (4): 35–40.
- National committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 1990. NCCLS, Villanova, PA. Approved Standard, Document M2-A4.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically. 1990. NCCLS, Villanova, PA. Approved Standard, Document M7-A2.
- Sisson G, Goodwin A, Raudonikiene A, et al. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 2002; 46: 2116–2123.